Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · AXE COMPUTE INC. (AGPU)

Axe Compute sells Helomics to DataMeds AI for DataMeds shares and a $1,363,672 note

Neutral Impact 4 of 5 m&a Written later

Axe Compute agreed on September 11, 2026 to sell Helomics, its last operating business from its former identity as Predictive Oncology, to DataMeds AI (NASDAQ: MEDS). The sale closed the same day, and the company received DataMeds stock and a convertible note rather than cash. The filing says the sale completes Axe Compute's transition to a pure-play neocloud GPU-as-a-Service company.

Key points

  • Consideration: 636,328 DataMeds common shares, equal to 19.99% of DataMeds shares outstanding before closing, plus a $1,363,672 convertible note with a $1.00 per share conversion price.
  • The shares and conversion shares are restricted securities subject to a 12-month lock-up from the closing date.
  • Axe Compute must pay the remaining base rent on two Pittsburgh, Pennsylvania leases used by Helomics through the current lease terms; other lease costs fall to DataMeds and Helomics.
  • The company issued a press release on September 15, 2026 announcing completion of the sale.

The filing

CompanyAXE COMPUTE INC. (AGPU)
Form8-K, current report
Filed with the SECSep 17, 2026, 4:05 PM ET
Accession number0001171843-26-006093

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.